Yes, the way it reacted today they most likely have the buyers lined up and will price after 5 o'clock PST or tomorrow morning before the market opens. This will probably be a case where even if it's priced at 7.50 or 8.00, it may never reach those levels because of the demand. We'll have to wait and see but that's the way it's reacting now. JMHO of course.....gl
Recent TCRT News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 12:00:43 PM
- Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models • GlobeNewswire Inc. • 05/18/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:29:30 PM
- Valion Bio Appoints Melinda Lackey as General Counsel • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:30:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:18:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:15:27 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2026 09:14:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 08:32:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:33:22 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 03/05/2026 04:33:21 PM
- Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders • GlobeNewswire Inc. • 03/02/2026 11:30:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 11:29:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:15:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:15:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/15/2026 09:15:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:30:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 10:18:31 PM
- Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8) • Edgar (US Regulatory) • 12/11/2025 10:17:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2025 02:32:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2025 02:26:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2025 02:26:01 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/07/2025 09:34:28 PM
